Sol-Gel Reports First Quarter 2024 Financial Results And Provides Corporate Updates

Related Keywords

United Kingdom ,Canada ,Israel ,Hong Kong ,China ,New Jersey ,United States ,Taiwan ,Macau ,America ,Beimei Pharma ,Gilad Mamlok ,Padagis Roflumilast ,Gel Technologies Ltd ,Company Annual Report On Form ,Arcutis Biotherapeutics Inc ,Pellepharm Inc ,Exchange Commission ,Padagis Israeli Pharmaceuticals ,Nasdaq ,Us District Court ,Gorlin Syndrome ,Asset Purchase Agreement ,Product Generic ,Gel Technologies ,Recent Corporate ,Abbreviated New Drug Application ,Roflumilast Cream ,North America ,Executive Officer ,First Quarter ,Year Ended ,Breakthrough Drug ,Private Securities Litigation Reform Act ,Annual Report ,Gel Contact ,Sol Gel Technologies ,